A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, ...

Anaplastic thyroid cancer is an extremely rare and fast-growing cancer. Just 500-800 people in the U.S. are diagnosed with it each year. It’s also very deadly. Anaplastic thyroid cancer makes up only ...

Differentiated thyroid cancer shows a comparable prognosis in patients with immunocompromised vs immunocompetent status, a ...

This guide provides an informative and educational overview of stage 3 papillary thyroid cancer (PTC) to help drive a ...

In most cases, treatments are successful in curing or controlling papillary thyroid cancer. Surgery is the main treatment option for this disease, though doctors may also recommend radiation therapy.

Differentiated thyroid cancer is the most frequently diagnosed thyroid cancer in the U.S. Recently, the American Thyroid Association (ATA) released new practice guidelines for Differentiated thyroid ...

Thyroid nodules are common, and thyroid cancer is often curable—but when should you be concerned? Marcus Monroe, MD, head and neck cancer expert at University of Utah Health, explains what your ...

Papillary thyroid cancer staging depends on age, with stage 2 involving distant spread in younger patients and larger tumors or regional spread in older patients. Diagnosis involves physical exams, ...

New research shows a link between PFAS, or forever chemicals, and increased risk for thyroid cancer. Forever chemicals are present in many products, including cleaning products and water-resistant ...

If you have been diagnosed with thyroid cancer, surgery is a standard and effective treatment. Oncologist Jason Hunt, MD, FACS, provides insights into the surgery process and after. Topics include the ...

In cancer terminology, "well-differentiated" means the cancer cells resemble the normal cells from which they grew. Well-differentiated cancers grow more slowly and have a better prognosis than ...

A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, ...